CellNovo
Biomedical device company committed to bringing new freedom and ease of use to people living with diabetes
CellNovo has raised €35M across 1 funding round from 4 investors, most recently a Series B round in Feb 2011. Based in Kings Road Swansea Waterfront, UK; founded 2002; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€35M
€34,847,253
Funding rounds
1
Investors
4
distinct backers
Active since
2011-02
latest 2011-02
Funding by year
EUR raised per yearCellNovo — funding by year — interactive chart.
Data table
| CellNovo — funding by year | |
|---|---|
| 2011 | €35M |
Signals
High confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2011-02-01 | Series B | €35M | Advent Venture Partners,Forbion,NBGI Ventures,NESTA Investments | View deal → |
Similar companies
same sector or countryGlobal coverage: FundingData